Skip to content
DraconiticResearch
Search Sources API
181,713 studies31 sourcesUpdated 42 min ago
PreprintCC BYbioRxiv

Degraded myelin is associated with cold hypersensitivity in paclitaxel-induced peripheral neuropathy

  1. 1University of Arkansas for Medical Sciences

Abstract

Cold allodynia is a debilitating symptom of chemotherapy-induced peripheral neuropathy (CIPN), a side effect of many chemotherapeutics, including paclitaxel (PTX). CIPN is highly prevalent and can lead to cessation of chemotherapy, threatening cancer patient survival. PTX induces cold-evoked pain in 60% of CIPN patients and this pain is a predictor for more severe neuropathy. Cold is transduced by primary sensory neurons in dorsal root ganglia (DRG). PTX can induce maladaptive changes in gene expression that lead to dysregulated nociceptor function. Previous work examining PTX-induced transcriptional changes have been unable to isolate mechanisms associated with pathological cold pain. The epigenetic changes that underlie long- lasting transcriptional changes in PTX-induced persistent cold hypersensitivity are not known. Following three consecutive cycles of PTX, we find that mice continue to exhibit cold hypersensitivity for a minimum of four weeks following the resolution of PTX-induced mechanical hypersensitivity. This exclusive cold hypersensitivity phenotype allows us to examine the mechanisms that specifically underlie pathological cold pain. During this period of PTX-induced cold hypersensitivity, we found decreased expression of genes whose expression is necessary for myelin sheath formation and maintenance, degraded myelin sheaths in the distal sciatic nerve, and decreased chromatin accessibility at genomic regions that contain binding motifs for pro-myelinating transcription factors. Our findings suggest that epigenetic-regulated myelin programs perpetuate myelin degradation and drive pathological cold pain. Our improved understanding of the specific mechanisms that maintain myelin degradation during cold hypersensitivity will improve cold pain management, facilitate the completion of cancer treatment, and improve the quality of life for chronic pain patients.

Related

  1. Characterization of diabetic peripheral neuropathy in a high-fat diet mouse model
    Guillaume Rastoldo, Alexis Chirpaz, Sarrah Tréport +9
    PLoS ONEPeer-reviewedCC BY 4.0Full textCell biologyNeuroscienceHALPLOS
  2. Biallelic PIGB Variants Cause Motor Neuropathy with Conduction Blocks and Peripheral Nerve Hyperexcitability
    Gorka Fernández-Eulate, Romain Duval, Marina Konyukh +32
    Annals of NeurologyPeer-reviewedCC BY-NC-NDFull textNeuroscienceHAL
  3. Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease
    Z. Sun, Z. Yang, X. Wang +6
    bioRxivPreprintAll rights reservedFull textBioinformatics & computational biologybioRxiv
  4. Corticosteroid-responsive eosinophilic meningomyelitis associated with peripheral eosinophilia in a cat: a case report
    Manon Guehl, Aude Morgane Canonne, Noëlle Cochet-Faivre +1
    Journal of Feline Medicine and Surgery Open ReportsPeer-reviewedCC BY-NCFull textGeneral biologyHAL
  5. Neurodegenerative disease risk associated with gene expression in peripheral monocytes across ancestries
    Aaron Z. Wagen, Regina H. Reynolds, Jia Nee Foo +7
    Communications BiologyPeer-reviewedCC BY 4.0Full textGenetics & genomicsCrossref
BibTeX
@misc{mora2026degraded,
  title = {{Degraded myelin is associated with cold hypersensitivity in paclitaxel-induced peripheral neuropathy}},
  author = {L. R. Mora and M. G. Bishop and K. A. Rodriguez and D. M. Redling and R. Fox and A. M. Ezeldin and E. Zheng and K. E. Stephens},
  howpublished = {bioRxiv},
  year = {2026},
  month = may,
  doi = {10.64898/2026.05.29.728780},
  url = {https://www.biorxiv.org/content/10.64898/2026.05.29.728780v2},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Degraded myelin is associated with cold hypersensitivity in paclitaxel-induced peripheral neuropathy
AU  - L. R. Mora
AU  - M. G. Bishop
AU  - K. A. Rodriguez
AU  - D. M. Redling
AU  - R. Fox
AU  - A. M. Ezeldin
AU  - E. Zheng
AU  - K. E. Stephens
PY  - 2026
DA  - 2026/05/29
PB  - bioRxiv
DO  - 10.64898/2026.05.29.728780
UR  - https://www.biorxiv.org/content/10.64898/2026.05.29.728780v2
AB  - Cold allodynia is a debilitating symptom of chemotherapy-induced peripheral neuropathy (CIPN), a side effect of many chemotherapeutics, including paclitaxel (PTX). CIPN is highly prevalent and can lead to cessation of chemotherapy, threatening cancer patient survival. PTX induces cold-evoked pain in 60% of CIPN patients and this pain is a predictor for more severe neuropathy. Cold is transduced by primary sensory neurons in dorsal root ganglia (DRG). PTX can induce maladaptive changes in gene expression that lead to dysregulated nociceptor function. Previous work examining PTX-induced transcriptional changes have been unable to isolate mechanisms associated with pathological cold pain. The epigenetic changes that underlie long- lasting transcriptional changes in PTX-induced persistent cold hypersensitivity are not known. Following three consecutive cycles of PTX, we find that mice continue to exhibit cold hypersensitivity for a minimum of four weeks following the resolution of PTX-induced mechanical hypersensitivity. This exclusive cold hypersensitivity phenotype allows us to examine the mechanisms that specifically underlie pathological cold pain. During this period of PTX-induced cold hypersensitivity, we found decreased expression of genes whose expression is necessary for myelin sheath formation and maintenance, degraded myelin sheaths in the distal sciatic nerve, and decreased chromatin accessibility at genomic regions that contain binding motifs for pro-myelinating transcription factors. Our findings suggest that epigenetic-regulated myelin programs perpetuate myelin degradation and drive pathological cold pain. Our improved understanding of the specific mechanisms that maintain myelin degradation during cold hypersensitivity will improve cold pain management, facilitate the completion of cancer treatment, and improve the quality of life for chronic pain patients.
ER  -